Our products will initially target the point-of-care (POC) and physician’s office laboratory (POL) market segments within the domestic and international in vitro diagnostics device market, with expansion predicted into retail pharmacy/over-the-counter (OTC), clinical labs, and Health Care Associations. Our customers will include physicians, hospitals, emergency rooms, wholesale distributors, and pharmacies.


Market Strategy

Our products have been designed to offer a clear-cut differentiation with currently available tests for monitoring diabetes, kidney function and coagulation.

  • Lower cost

  • User convenience

  • Value of information

  • Facilitation of doctor-patient feedback

  • Therapeutic intervention










   Company                       Product                               Technology                           Markets                                  Investor Relations

   Company Overveiw           G1A Test                                Overview                                Overview                                  Shareholder Website

   Management                   ACR Test                                 G1A Test                                G1A Test                                  Corporate Profile & Governance

   Advisory Board                SimplySure PT-INR Test             ACR Test                                ACR Test                           

                                                                                    SimplySure PT-INR Test            SimplySure PT-INR Test       

                                                                                    Intellectual Property                                                      


  Publications                                    Contact               

  Corporate Information Series                                  

  Scientific Reviews  








© 2016 by Epinex Diagnostics Inc

Epinex-G1A-Glycated Albumin-Monthly Diabetes Test


  • w-facebook
  • Twitter Clean
  • White LinkedIn Icon